Buy or sell Strata Oncology stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Strata Oncology Stock

Strata Oncology is a precision oncology company dedicated to transforming cancer care.

Founded

2016

Notable Investors

Baird Capital

Headquarters

Ann Arbor MI, US

Total Funding

$128M

About Strata Oncology Stock

Strata Oncology is a precision oncology company dedicated to transforming cancer care by expanding patient access to precision medicine clinical trials and accelerating drug approval. Strata's national precision oncology platform serves the needs of patients, providers and drug developers by providing a link from patient screening to streamlined enrollment in mutation-matched clinical trials. Follow us on Twitter @StrataOncology.

Investors

Pfizer Venture Investments

RefleXion Medical, Strata Oncology

Wellington Capital Management

Strata Oncology

Funding History

June 2016$12.0M
May 2018$26.0M
July 2021$90.0M

Management

Co-founder & CEO

Dan Rhodes

Chief Medical Officer, Co-Founder

Scott Tomlins

Chief Financial Officer

Matt Martin

Vice President Clinical Operations

Kat Kwiatkowski

Board of Directors (Observer)

David Gregorka

Board Member, Investor

Jan Garfinkle

Board of Director

Keith Flaherty

Board Member

Nicole Walker

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 290K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo